Browse Title Index
| Issue | Title | |
| Vol 2, No 4 (2011) | Pathophysiology, diagnosis and treatment of disseminated intravascular coagulation | Abstract PDF (Polish) |
| Jerzy Windyga | ||
| Vol 10, No 3 (2019) | Perspectives of TRAIL and its analogs — based therapeutic strategies in hematooncology | Abstract PDF (Polish) |
| Karolina Piechna, Przemysław Juszczyński | ||
| Vol 11, No 2 (2020) | Pharmacological treatment of primary immune thrombocytopenia in adults | Abstract PDF (Polish) |
| Krzysztof Chojnowski | ||
| Vol 10, Supp. B (2019) | Phlebotomy as a treatment of transfusion related iron overload in a patient on effective treatment of myelodysplastic syndrome with azacytydine | Abstract PDF (Polish) |
| Hanna Ciepłuch | ||
| Vol 4, No 2 (2013) | PI3K-AKT axis in normal lymphoid development and B-cell tumors. Part I | Abstract PDF (Polish) HTML (Polish) |
| Maciej Szydłowski, Ewa Jabłońska, Przemysław Juszczyński | ||
| Vol 5, No 4 (2014) | PIM kinases as therapeutic targets in lymphoid and myeloid malignancies | Abstract PDF (Polish) HTML (Polish) |
| Przemysław Juszczyński | ||
| Vol 1, No 4 (2010) | Pitfalls in the diagnosis of B-cell lymphomas | Abstract PDF (Polish) |
| Monika Prochorec-Sobieszek | ||
| Vol 9, No 2 (2018) | Place of ruxolitinib in myelofibrosis treatment. | Abstract PDF (Polish) |
| Aleksandra Gołos, Joanna Góra-Tybor | ||
| Vol 8, No 1 (2017) | Planned pregnancy pregnancy in patient with chronic myelogenous leukemia treated with imatinib | Abstract PDF (Polish) HTML (Polish) |
| Ilona Seferyńska, Iwona Solarska, Krzysztof Warzocha | ||
| Vol 6, Supp. A (2015) | Plasma cell myeloma complicated with hyperviscosity syndrome in a patient with dementia of unknown origin | Abstract PDF (Polish) |
| Jakub Dębski, Lidia Usnarska-Zubkiewicz, Kazimierz Kuliczkowski | ||
| Vol 6, Supp. A (2015) | Plasma cell myeloma with predominant symptoms of bone disease-effective first-line treatment interrupted by low-energy pubic bone fracture — therapy complications management | Abstract PDF (Polish) |
| Marcin Rymko, Małgorzata Całbecka | ||
| Vol 3, No 3 (2012) | Plasma cell myeloma — management recommendation of the Institute of Hematology and Transfusion Medicine | Abstract PDF (Polish) |
| Jarosław Czyż, Krzysztof Warzocha | ||
| Vol 4, No 4 (2013) | Plasma cell myeloma — management recommendation of the Institute of Hematology and Transfusion Medicine | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Jamroziak, Jarosław Czyż, Krzysztof Warzocha | ||
| Vol 5, No 4 (2014) | Plasma cell myeloma — practical aspects of the diagnosis and treatment | Abstract PDF (Polish) HTML (Polish) |
| Grzegorz Charliński, Elżbieta Wiater | ||
| Vol 13, No 3-4 (2022) | Plasmablastic lymphoma in an HIV-negative patient with complete remission after chemotherapy with DA-EPOCH | Abstract PDF |
| Joseph Alburqueque-Melgarejo, Juan Carlos Roque-Quezada, Javier Dulanto Moscoso, Emanuel Salcedo Davila, Brady Beltrán Gárate | ||
| Vol 5, No 3 (2014) | Pleural effusion in a chronic myelogenous leukemia patient treated with dasatinib — a case report and disease management recommendations | Abstract PDF (Polish) HTML (Polish) |
| Elżbieta Patkowska, Joanna Góra-Tybor | ||
| Vol 9, No 2 (2018) | Polish experts’ opinion concerning brentuximab vedotin in treatament of primary cutaneous lymphomas with CD30 expression | Abstract PDF (Polish) |
| Małgorzata Sokołowska-Wojdyło, Jan Walewski, Wiesław W. Jędrzejczak, Tadeusz Robak, Monika Prochorec-Sobieszek, Jan Maciej Zaucha, Alina Jankowska-Konsur, Monika Słowińska, Ewa Chmielowska, Lidia Rudnicka, Sebastian Giebel | ||
| Vol 12, No 2 (2021) | Polish Experts’ Position Statement on the use of granulocyte colony-stimulating factor in the treatment of chronic lymphocytic leukemia with venetoclax combined with rituximab | Abstract PDF |
| Elżbieta Iskierka-Jażdżewska, Krzysztof Giannopoulos, Sebastian Grosicki, Krzysztof Jamroziak, Tomasz Wróbel, Jan Maciej Zaucha, Marek Dudziński, Łukasz Bołkuń, Ewa Bodzenta, Joanna Drozd-Sokołowska, Agnieszka Samborska, Anna Wolska-Washer, Iwona Hus | ||
| Vol 12, No 2 (2021) | Polish Experts’ Position Statement on the use of granulocyte colony-stimulating factor in the treatment of chronic lymphocytic leukemia with venetoclax combined with rituximab | Details PDF |
| Elżbieta Iskierka-Jażdżewska | ||
| Vol 2, No 4 (2011) | Polish guidelines for the management of rare clotting factor deficiencies | Abstract PDF (Polish) |
| Krystyna Zawilska, Krzysztof Chojnowski, Anna Klukowska, Magdalena Łętowska, Andrzej Mital, Jacek Musiał, Maria Podolak-Dawidziak, Anetta Undas, Jerzy Windyga, Joanna Zdziarska w imieniu Grupy ds. Hem Transfuzjologów | ||
| Vol 8, No 4 (2017) | Polish Society of Clinical Oncology position statement on the urgent need of introduction of national standards for utilization of biologic drugs | Abstract PDF (Polish) |
| Piotr J. Wysocki, Maciej Krzakowski, Jan Walewski, Monika Duszyńska, Marek Z Wojtukiewicz, Dariusz Kowalski, Rafał Zyśk | ||
| Vol 5, No 2 (2014) | Polycythemia vera and essential thrombocythemia — diagnosis and therapy | Abstract PDF (Polish) HTML (Polish) |
| Joanna Góra-Tybor | ||
| Vol 13, No 1 (2022) | Polyserositis (pericarditis and bilateral pleural effusion) after COVID-19 mRNA vaccine | Abstract PDF |
| Katarzyna Korzeniowska, Artur Cieślewicz, Anna Flotyńska, Anna Jabłecka | ||
| Vol 7, No 3 (2016) | Pomalidomide in combination with clarithromycin and dexamethasone for double refractory plasma cell myeloma — a case report and review of literature | Abstract PDF (Polish) |
| Agnieszka Szeremet, Tomasz Wróbel | ||
| Vol 8, Supp. A (2017) | Pomalidomide in combination with clarithromycin and dexamethasone for double refractory plasma cell myeloma — a case report and review of literature | Abstract PDF (Polish) |
| Agnieszka Szeremet | ||
| 301 - 325 of 544 Items | << < 8 9 10 11 12 13 14 15 16 17 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
